The need to have viable, metabolically active cells to heal wounds is well recognized, because there is clear evidence that cellular dysfunction delays healing. This suggests that addition of metabolically active cells to a delayed healing tissue could enhance the healing of the tissue. Therefore, we examined the ability of an interactive wound dressing composed of human keratinocytes or fibroblasts grown on microporous bio-reactor beads and placed into a polyethylene bag to facilitate the delayed healing of wounds in nude mice. A 1 x 1 cm wound was made on the backs of nude mice, and the dressing with or without viable cells was placed on the wound for 8 to 24 days, with dressing changes every other day. Wound area and time to heal measurements were compared after various interventions including freeze-thawing. The data shows that the interactive wound dressing was more effective than the control dressings (p<0.05) and that keratinocytes were more effective than fibroblasts in wound healing (p<0.05). Freezingthawing of the interactive wound dressings destroyed the activity of the dressing. Studies examining cells using a live/ dead viability assay showed that both keratinocytes and fibroblasts were alive after 2 days on the mice. Surprisingly, human fibroblasts appeared to exhibit bridging behavior that is indicative of fibroblast proliferation. We conclude that a simple interactive wound dressing using either keratinocytes or fibroblasts can enhance the healing of wounds in nude mice. Healing of damaged tissue is an energy dependent pro-
Healing of damaged tissue is an energy dependent pro-
IWD
Interactive wound device cess requiring multiple healthy cell types synthesizing and secreting numerous protein regulatory molecules. Recently, studies have suggested that failure to heal wounds may result from cellular dysfunction resulting ulcers and one-half million pressure ulcers in the United in, among other factors, a lack of essential growth factors States. Although several therapeutic approaches hold within the wound bed. [1] [2] [3] The need for innovative theragreat promise, the application of healthy human cells pies to treat this cellular dysfunction is a key component to a non-healing wound is an attractive wound healing to the successful treatment of the 3 million diabetic foot strategy.
The placement of human keratinocytes on various types of carrier dressings has been very successful. One skin substitutes is unclear. Studies by Achauer et al. 11 ment cages. Every other day the mice were returned to the laminar flow hood, lightly restrained while wound have shown that keratinocytes will attach and proliferate in immunosuppressed burn patients. However, it is unarea and photographic measurements were obtained, and the dressing replaced and secured. The animal protoclear if these events occur in immunocompetent hosts. Long-term studies of burn wounds transplanted with kercol was approved by the Institutional Animal Use Committee of the VA Ann Arbor Healthcare System. atinocytes show that keratinocyte grafts do not produce the normal epidermal and dermal elements present in non-wounded skin. 12 
Preparation of human keratinocytes
Human keratinocytes were obtained from breast skin There is great clinical interest in the development of cell based wound therapies using a collagen matrix as a removed during surgical procedures performed at the University of Michigan Hospital. Informed consent was platform for cells. The skin substitute, Apligraf , composed of neonatal keratinocytes and fibroblasts, is comobtained from all patients, and the University of Michigan Institutional Review Board approved this protocol. Skin mercially available for the treatment of venous stasis ulcers.
13-15 Dermagraft, also a skin substitute, is comwas harvested in accordance with the guidelines of the American Association of Tissue Banks. The split thickposed of fibroblasts and a collagen matrix and is currently in the final stages of clinical trials to treat diabetic ness skin was placed, dermis side down, into 150 mm Petri dishes, cut into small pieces (2 cm x 0.3 cm) and foot ulcers.
Pruitt and Levine 16 suggested that the ideal wound soaked in a sterile solution of 30 mM HEPES, 10 mM glucose, 3 mM KCl, 130 mM NaCl, 1mM Na 2 HPO 4 buffer, dressing shows tissue compatibility, adherence to the wound surface, flexibility, elasticity, and protection pH 7.4 containing 50 units of penicillin and 50 g streptomycin (Sigma Chemical Co, St. Louis, MO). After soaking against bacteria. These attributes contribute significantly to the wound healing effect. Skin substitutes and IWDs, the tissue for 1-2 hours at 4ЊC, the buffer was aspirated, and 0.09% trypsin (Sigma, Type IX) in the penicillin and in contrast to traditional dressings, have the added benefit of living cells. This component may significantly add streptomycin buffer was added to the dishes. Following overnight trypsinization at room temperature, the ento the wound healing potential, although evaluating the efficacy of IWD and skin substitutes may be complex zyme solution was removed and modified complete MCDB 153 medium (Sigma) containing trypsin soybean given the variety of materials present in the device. These materials include a biological matrix, dressing materials, inhibitor was added to the skin pieces. The dermis was separated from the epidermis, and the epidermal basal and a variety of living cells. Therefore, skin substitutes and IWDs provide many of the attributes of the ideal keratinocytes were gently scraped from both segments of the skin. The cell suspension was pooled into 50 ml dressing. 16 In this study, we tested the hypothesis that normal conical centrifugation tubes, subjected to low speed centrifugation at room temperature, and re-suspended in 50 human allogeneic keratinocytes or fibroblasts grown on a platform of polyethylene coated silica microcarrier beads ml of complete medium plus 2% chelexed fetal bovine serum (Sigma). The keratinocytes were counted using a enclosed in fine mesh fabric are an effective IWD. Our results suggest a powerful wound healing effect by this hemocytometer, and 20 x 10 6 keratinocytes were plated into T-75 Corning plastic flasks and grown at 37ЊC with type of IWD. 5% CO 2 , in a humidified incubator. Three days later, growth medium was removed and
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complete MCDB 153 without serum was added. The keratinocytes were re-fed every other day and passaged durAll surgical procedures were performed under sterile conditions within a laminar flow hood located within a ing the log phase of growth. The keratinocytes were trypsinized using 0.025% trypsin (type IX, Sigma) plus containment area where the nude mice were housed. Five-week-old female Nu/J mice (Jackson Labs, Bar Har-0.01% EDTA in HEPES buffer. The monolayers were washed with the buffer twice and then 2-3 ml freshly bor, ME) were anesthetized with metofane (Mallinckrodt, Veterinary, St Louis, MO) and an area on the dorsum made enzyme solution (or frozen aliquot) was added. After 1 minute at 37ЊC, the enzyme solution was gently cleansed with ethanol. Using fine surgical scissors, a full thickness wound approximately 100 mm 2 in area was suctioned off and the flasks held at 37ЊC for 2-3 minutes, until the cell sheets came off with gentle tapping of the created. The wound dressings were secured to the wound using surgical staples to the cephalad end, covered with flask bottom. The media was neutralized with 1-3 ml of MCDB 153 medium plus 0.03% trypsin soybean inhibitor a Band-Aidி (Johnson & Johnson, New Brunswick, NJ) before the mice were returned to their biohazard contain-(Sigma). The cells were counted, centrifuged and plated at 0.5 ‫מ‬ 1.0 ‫ן‬ 10 6 cells per T-75 flask. Cells were pasinto 15 ml Dulbecco's Modified Eagle Medium (DMEM, Sigma) plus 10% fetal bovine serum (complete medium) saged 3 to 4 times. and grown in a T-75 flask under 5% CO 2 at 37ЊC. The Processing of microcarrier beads primary cultures were passaged using 0.03% trypsin and Five grams of Cytoline 1 (Amersham, Piscataway, NJ) 0.01% EDTA at a 1:3 split. Ten flasks of an adult human beads were autoclaved for 10 minutes in 40 ml deionized fibroblast cell strain were trypsinized, resulting in 38 X water in a 125 ml Erlenmeyer flask. The beads were 10 6 cells in a volume of 10 ml of DMEM complete medium. cooled, the water aspirated, and 80 ml of deionized water Processed Cytoline 1 beads were prepared for culture was added. The mixture was agitated at moderate speed by removing the PBS and soaking the beads in twice the on a Labline orbital shaker for 10 minutes. The water volume of complete medium for 48-72 hours. After the was removed, 80 ml of deionized water added, and the soaking medium was removed, 100 ml of fresh complete washing process repeated two more times. The beads medium was added. were transferred to a 250 ml plastic tube, the water was Prior to plating the cells onto Cytoline 1 beads, the removed and 40 ml 0.1N NaOH was added. The beads medium was removed from the beads and 10 ml of fibrowere incubated at room temperature overnight, the blast cell suspension was added to 20 ml of the packed NaOH solution was removed and the beads were resusmicrocarrier beads, in a sterile 50 ml centrifuge tube. pended in 50 ml of deionized water. The aliquot was
The cells and beads were gently mixed and transferred transferred to a 125 Erlenmeyer flask where the wash to a 250 ml sterile glass bottle and placed in a 5% CO 2 step was repeated five times until the final pH was <8.0.
incubator at 37ЊC. After one hour, 100 ml additional comThe water was aspirated and the beads were again susplete medium was added and the cells and beads were pended in 40 ml PBS minus Mg‫םם‬ and Ca‫,םם‬ and incubated overnight. The top of the bottle allowed gasautoclaved for 30 minutes at 121ЊC.
sing of the cell/bead suspension. After 24 hours, the cell/ microcarrier bead suspension was transferred to a Keratinocyte cultures on microcarrier beads Kontes 250 ml bio-reactor, and grown with gentle stirring Prepared beads were suspended in MCDB 153 complete under standard incubator conditions. One-fourth the memedium in a culture bottle and conditioned at 37ЊC with dium volume of the fibroblast/bead suspension was re-5% CO 2 for 48 hours. The medium was aspirated and 10 freshed every second day. to 15 ml of medium was added. The medium was removed and 20 x 10 6 cells per 1 ml of beads were added. This Preparation of bead bags mixture was gently swirled once an hour for 3 hours, Microcarrier beads coated with cells were contained then incubated overnight. The cells and beads were dewithin a delnet (Applied Extrusion Technologies, Inc., canted into a roller bottle and 50 ml of medium was Peabody, MA) bag approximately 23 ‫ן‬ 25 mm in size. added. Five ml of cells and beads were removed from Three seams were created in the pouch with an Impulse the glass roller bottle and grown in a T-25 flask to deterHeat Sealing Unit (American International Electric Co., mine the growth of the cells on the plastic bottom of the Santa Fe Springs, CA), and then gas sterilized with ethylflask in the presence of the beads. The roller bottle was ene oxide. The cell/bead suspension (250 l) was added incubated overnight at 37ЊC, after which 100 ml addito the delnet bag with a glass pipet. After the beads tional medium was added to the roller bottle and the containing cells were loaded into the bag, the final seam rotation of the roller bottle was initiated. The rotation was created with the Impulse Heat Sealing Unit, and the rate was one turn per 15 seconds. When the cells were assembled bags were placed into tissue culture media re-fed every 48 hours, an aliquot of medium was removed until used. The bag and bead assembly was performed and replaced by fresh medium.
in a laminar flow tissue culture hood.
Preparation of fibroblast populated beads
After separation of the dermis from the epidermis and Measurement of wound area Determination of the total wound area was performed the removal of most of the adhering cells, the dermal skin layer was put into collagenase/phosphate buffered as previously described. 17 Briefly, the area of the wound was traced onto a transparent sheet (Labelon Corp, Canasaline solution (PBS, 50 mg collagenase type XI, Life Technologies, New York). After gentle stirring at room daigua, NY) with a fine marker. The transparent sheet was photocopied and the copy was scanned using an HP temperature for one hour, the cells were filtered from the dermal suspension using a 240-micron mesh filter.
ScanJet 4C (Hewlett-Packard Co, Boise, ID). Tissue area was calculated with a non-rectangular area analysis used The cells were centrifuged in a 50 ml tube at 1000 rpm at room temperature, 1 ‫מ‬ 2 ‫ן‬ 10 6 cells were placed by NIH image 1.44. The data was expressed as millimeters squared. Mean and standard deviation were calculated using Statworks (SPSS, Inc.).
Histologic evaluation
Excised wounds were placed into 10% buffered formalin, processed in an IL MVP Tissue Processor (Instrumentation Laboratory, Lexington, MA), then embedded in paraffin utilizing the clinical histology section of the Ann Arbor VA Medical Center. The tissues were cut into 5 m sections and stained using routine hematoxylin and eosin staining. Microscopic examination and photography of the slides were done on a Zeiss Axiophot photomicroscope (Carl Zeiss, Germany). Human keratinocytes that were grown on Cytoline 1 miwas taken 5 days after the cells were inoculated.
crocarrier beads were stained with Kreyberg stain. 18 The cells and beads were fixed in 6% trichloroacetic acid for at least one hour before they were rinsed in 70% ethanol for five seconds and distilled water twice. Thereafter, covered with a Band-Aidி as an overdressing, and the they were stained with Mayer's Hematoxylin for 4 midressing replaced every other day for the 8-day duration nutes and rinsed with running tap water for 3 minutes of the experiment. Before each dressing change, the to stain the nuclei blue. The cells and beads were stained wounds were debrided and the area measured. The rewith 1% aqueous erythrosin for 3 minutes and rinsed with sults of this pilot experiment are shown in Figure 2 . tap water for 10 seconds before rinsing with 80% ethanol
The data indicate that wound size was reduced in both and again with tap water. Thereafter, the microcarrier groups, but the reduction was greater at days 2, 4, and beads were suspended in tap water, and examined and 8 in the IWD group (p < 0.05). The wound healing effect photographed using a Nikon inverted microscope.
was most pronounced at day 4 (p < 0.008). These wounds had a confluent epidermis covering the wounded area Cell viability assay A two-color fluorescence dye assay (LIVE/DEAD ᭨ Viability Kit, Molecular Probes, OR) was used to examine the number of viable cells on the microcarrier beads after placement in the mice wounds. A working solution of 4M ethidium homodimer-1 and 2M calcein AM in sterile phosphate buffered saline solution was added to the cell coated beads in a Petri dish. After a 20-minute incubation at 37ЊC, the cell-coated beads were viewed under a fluorescence microscope.
RESULTS
We examined how keratinocytes interacted with silica/ polyethylene microcarrier beads contained within a polyethylene mesh bag. Figure 1 shows keratinocytes grown on microcarrier beads photographed on a tissue culture dish. Note the irregularity of the beads and high density of keratinocytes achieved on the microcarrier beads.
Initially, we tested the wound healing effectiveness of human keratinocytes used as an IWD on nude mice either the IWD or mesh bag alone. All wounds were after they were healed ( Figure 3) and there was evidence that dermal components had regenerated. We proposed that the wound healing effect was related to the contribution of living keratinocytes. Therefore, we snap froze the IWD before application to the wound. In this experiment, there were three groups of animals (n ‫ס‬ 8) with a control group treated with the Band-Aidி cover dressing only. The data in Figure 4 Figure 5. A three-armed study of wound healing comparing beads only in a Delnet bag, Delnet, and IWDs. The wounds were measured until they were healed. The data (mean ‫ע‬ SD) shows a statistically significant reduction in wound area using IWDs starting at day 6 (p <0.05). All the wounds in the IWD group were healed by day 20. . Wound healing potential of keratinocytes and fibroblasts on beads in a bag were compared over 10 days. The mean area ‫ע(‬ SD) was plotted between the two groups (n ‫ס‬ 10). Note that by day 4, the keratinocyte preparation was substantially more active than the fibroblasts. The average number of beads in the fibroblast group was higher (n ‫ס‬ 112) than in Figure 4 . Results of a three-armed study comparing the IWD, the keratinocyte bags (n ‫ס‬ 80). frozen IWDs and the Band-Aidி dressing. In these experiments, IWDs showed a statistically significant reduction in wound area that was noted at day 10 (p <0.05). IWDs and frozen IWDs appeared to have identical wound healing curves prior to that indicates there was no difference between frozen kera- better than the control wounds (p < 0.05). In the three of fibroblast populated microcarriers on wound healing in the mouse. Again, nude mice (n ‫ס‬ 18) were equally groups, all wounds were healed by day 28.
Because the IWD is assembled from several different divided into groups and treated either with keratinocyte populated wound devices or fibroblast coated beads. In components, e.g. Delnet bag, microcarrier beads, etc, we sought to determine the contribution of each component a 10-day trial, the data as presented in Figure 6 show a highly significant difference in healing between keratinoto the wound healing effect. Therefore, 8 mice in three groups treated with either Delnet bags, microcarrier cytes and fibroblasts in the IWD (p < 0.004). The reduction in wound area was greatest at day 6. The data beads in Delnet bag, or complete IWD, were studied for their vulnerary activity. The wounds were debrided, suggests that different cell types function differently inside the IWD. measured, and the dressings changed every other day. The data in Figure 5 shows statistically significant reducIn a final series of experiments, we determined the longevity of human or murine fibroblasts or human keration in wound area in the mice treated with complete IWDs starting on day 6 (p < 0.05). This effect persisted tinocytes in the IWD after they were placed in the wound. Using a live/dead assay, IWDs were removed from the throughout the experiment. Eighty percent of mouse wounds in the IWD group healed within 14 days.
wound bed after they were in contact with the wounds for 1, 2, or 3 days. Figure 7 shows that human fibroblasts These data all suggested that a wound healing effect was produced only when IWDs contained keratinocytes.
are alive at 3 days (lower left) with little evidence of dead cells. Note that the fibroblasts appear to be bridging Therefore, we tested the hypothesis that any cell would have wound healing properties by examining the effect between the beads. The mouse fibroblasts (upper right)
show areas of orange staining, suggestive that some cells nize that these predictions may not be sustainable in human wounds. Only clinical trials will provide the anare dying. However, the mouse fibroblasts were alive at days 1 and 2 (data not shown). The keratinocytes appear swer. to have some cells that are alive, although there is evidence of dying cells at 3 days.
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